Jules A Musing Net Worth & Insider Trades
Jules A Musing - Director, Therapeuticsmd, Inc
What is Jules A Musing's Net Worth?
The current estimated net worth of Therapeuticsmd, Inc's Director, Jules A Musing, is estimated to be about $150.77K . Jules A Musing owns about 5,000 units of Therapeuticsmd, Inc common stock. In the last 8 years at Therapeuticsmd, Inc, Jules A Musing has sold an estimated value of $100.92K worth.
What is Jules A Musing's Past Insider Trading?
Jules A Musing's largest purchase order was 6,318 units , worth over $13.58K on August 28, 2013. Jules A Musing's largest sale order was 17,400 units , worth over $100.92K on March 1, 2019. In total, Jules A Musing has made about 14 transactions over 8 years of their time at Therapeuticsmd, Inc. Jules A Musing usually trades in August and June, with the busiest year in 2013.
Jules A Musing
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jules A Musing's' Mailing Address?
- Mailing address is 9 Innovation Way, Suite 100 Newark DE 19711 DE
Therapeuticsmd, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Robert G. Finizio | 2020 | $600,000 | $1,524,751 | - | $600,000 | $21,785 | $2,746,536 |
| Robert G. Finizio | 2019 | $600,000 | - | $2 | $600,000 | $22,218 | $1,222,220 |
| John C.K. Milligan, IV | 2020 | $450,000 | $1,479,105 | - | $315,000 | $31,285 | $2,275,390 |
| John C.K. Milligan, IV | 2019 | $450,000 | - | $645,956 | $315,000 | $29,683 | $1,440,639 |
| Edward Borkowski | 2020 | $430,000 | - | $3,599,967 | $365,500 | $81,687 | $4,477,154 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm
What are Therapeuticsmd, Inc's Past Insider Trades?
Therapeuticsmd, Inc's most recent insider trade came on August 1, 2022 by Rubric Capital Management Lp and Efraim David Rosen who bought 580,000 units worth $15M . In the last 9 years, insiders at Therapeuticsmd, Inc have sold an estimated value of $50.32M and bought an estimated value of $20.27M worth of shares. Insider trading is most common in March, with the busiest year in 2018. The most active traders at the company are John C.K. Milligan IV, Secretary/CEO subsidiary, Robert G Finizio, CEO, and Tommy G Thompson, Director .
TherapeuticsMD, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||